China’s booming innovation ecosystem is catching the eye of global giants – and could unlock breakthroughs for people worldwide 🌐. Juergen Eckhardt, Executive VP at pharmaceutical titan Bayer, told CGTN that the country’s rapid advancements are reshaping how companies approach healthcare solutions.
💡 'China has always been a key market, but what’s exciting now is the explosion of creativity here,' said Eckhardt, who leads Bayer’s LEAPS innovation arm. From AI-powered drug discovery to next-gen biotech, he sees Chinese researchers 'writing the playbook for 21st-century medicine.'
The Fortune 500 firm plans to tap into this momentum, channeling local insights to benefit patients globally 🩺. With China’s healthcare market projected to hit $2.4 trillion by 2030, collaborations could accelerate treatments for everything from rare diseases to climate-related health challenges.
📈 Young professionals take note: Eckhardt’s comments highlight how Asia’s tech hubs are becoming innovation equalizers – where a startup in Shenzhen might inspire solutions deployed from Berlin to Buenos Aires.
